Submissions from 2014
Predicting risky choices from brain activity patterns, S. M. Helfinstein, T. Schonberg, E. Congdon, K. H. Karlsgodt, J. A. Mumford, F. W. Sabb, T. D. Cannon, E. D. London, R. M. Bilder, and R. A. Poldrack
Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy, T. Hirota, S. Schwartz, and C. U. Correll
Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients, P. Ifteni, C. U. Correll, V. Burtea, J. M. Kane, and P. Manu
Rapid clozapine titration in treatment-refractory bipolar disorder, P. Ifteni, C. U. Correll, J. Nielsen, V. Burtea, J. M. Kane, and P. Manu
Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report, P. Ifteni, M. A. Moga, V. Burtea, and C. U. Correll
Effectiveness and safety of rapid clozapine titration in schizophrenia, P. Ifteni, J. Nielsen, V. Burtea, C. U. Correll, J. M. Kane, and P. Manu
A schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure, T. Ikuta, B. D. Peters, S. Guha, M. John, K. H. Karlsgodt, T. Lencz, P. R. Szeszko, and A. K. Malhotra
Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis, T. Ikuta, D. G. Robinson, J. A. Gallego, B. D. Peters, P. Gruner, J. M. Kane, M. John, S. Sevy, A. K. Malhotra, and P. R. Szeszko
Abnormal cingulum bundle development in autism: A probabilistic tractography study, T. Ikuta, K. M. Shafritz, J. Bregman, B. D. Peters, P. Gruner, A. K. Malhotra, and P. R. Szeszko
Mitochondrial DNA Mutations and Cognition: A Case-Series Report, G. Inczedy-Farkas, J. W. Trampush, D. P. Forintos, D. Beech, M. Andrejkovics, Z. Varga, V. Remenyi, B. Bereznai, A. Gal, and M. J. Molnar
Altered white matter microstructure is associated with social cognition and psychotic symptoms in 22q11.2 microdeletion syndrome, M. Jalbrzikowski, J. E. Villalon-Reina, K. H. Karlsgodt, D. Senturk, C. Chow, P. M. Thompson, and C. E. Bearden
The significance of an isolated elevated TSH level in a depressed patient: a clinical commentary, R. T. Joffe and T. B. Sullivan
Clinical and cost implications of treating schizophrenia: safety, efficacy, relapse prevention, and patient outcomes, J. M. Kane, C. U. Correll, P. D. Harvey, and M. Olfson
Financial incentives improve adherence to maintenance antipsychotic treatment, John Kane
Technology-based interventions in health care, John Kane
Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia: Findings From a 12-Week, Randomized, Double-Blind, Placebo-Controlled Study, John Kane, T. Peters-Strickland, R. A. Baker, P. Hertel, A. Eramo, N. Jin, P. P. Perry, M. Gara, R. D. McQuade, R. Sanchez, and +1 additional author
Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis, John Kane, C. Zhao, B. R. Johnson, R. A. Baker, A. Eramo, R. D. McQuade, A. R. Duca, R. Sanchez, and T. Peters-Strickland
Altered relationships between age and functional brain activation in adolescents at clinical high risk for psychosis, K. H. Karlsgodt, T. G. M. van Erp, C. E. Bearden, and T. D. Cannon
Brief Pulse and Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy (ECT) for Major Depression: Efficacy, Effectiveness, and Cognitive Effects, C. H. Kellner, S. M. McClintock, W. V. McCall, G. Petrides, R. G. Knapp, R. D. Weiner, R. C. Young, R. M. Greenberg, M. V. Rudorfer, S. H. Lisanby, and +2 additional authors
The Relation Between Diabetes Self-Efficacy and Psychological Distress Among Older Adults: Do Racial and Ethnic Differences Exist?, G. Kim, Ruth Shim, K. L. Ford, and T. A. Baker
A Call to Restructure Psychiatry General and Subspecialty Training, P. Kirwin; M. Conroy; C. Lyketsos; Blaine Greenwald; B. Forester; C. Devries; II Ahmed; I. Wiechers; K. Zdanys; D. Steffens; and C. F., 3rd Reynolds
Effects of the child-perpetrator relationship on mental health outcomes of child abuse: It's (not) all relative, L. J. Kiser, C. S. Stover, C. P. Navalta, J. Dorado, J. M. Vogel, J. K. Abdul-Adil, S. Kim, R. C. Lee, R. Vivrette, and E. C. Briggs
Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials, Taishiro Kishimoto, A. Robenzadeh, C. Leucht, S. Leucht, K. Watanabe, M. Mimura, M. Borenstein, John Kane, and Christoph Correll
The CSMD1 genome-wide associated schizophrenia risk variant rs10503253 affects general cognitive ability and executive function in healthy males, E. Koiliari, P. Roussos, E. Pasparakis, T. Lencz, Anil Malhotra, L. J. Siever, S. G. Giakoumaki, and P. Bitsios
Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities, Jeremy Koppel, C. Acker, P. Davies, O. L. Lopez, H. Jimenez, M. Azose, Blaine Greenwald, P. S. Murray, C. M. Kirkwood, J. Kofler, and R. A. Sweet
Optimal treatment of Alzheimer's disease psychosis: challenges and solutions, Jeremy Koppel and Blaine Greenwald
Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease, Jeremy Koppel, H. Jimenez, M. Azose, C. D'Abramo, C. Acker, J. Buthorn, Blaine Greenwald, J. Lewis, M. Lesser, Z. Liu, and P. Davies
Psychosis in Alzheimer's Disease is Associated with Frontal Metabolic Impairment and Accelerated Decline in Working Memory: Findings from the Alzheimer's Disease Neuroimaging Initiative, Jeremy Koppel, S. Sunday, Terry Goldberg, P. Davies, E. Christen, Blaine Greenwald, and Initi Alzheimer's Dis Neuroimaging
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease, Jeremy Koppel, V. Vingtdeux, P. Marambaud, C. d'Abramo, H. Jimenez, M. Stauber, R. Friedman, and P. Davies
Positive and negative subclinical symptoms and MCCB performance in non-psychiatric controls, C. Korponay, G. C. Nitzburg, Anil Malhotra, and P. DeRosse
Emerging drugs for schizophrenia: an update, L. S. Koster, M. Carbon, and Christoph Correll
The influence of neighborhood characteristics on police officers' encounters with persons suspected to have a serious mental illness, S. Krishan, R. Bakeman, B. Broussard, S. L. Cristofaro, D. Hankerson-Dyson, L. Husbands, A. C. Watson, and Michael Compton
Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial, J. R. Larsen, L. Vedtofte, J. J. Holst, P. Oturai, A. Kjaer, Christoph Correll, T. Vilsboll, and A. Fink-Jensen
Symptomatic and functional remission of subjects at clinical high risk for psychosis: A 2-year naturalistic observational study, T. Y. Lee, S. N. Kim, Christoph Correll, M. S. Byun, E. Kim, J. H. Jang, D. H. Kang, J. Y. Yun, and J. S. Kwon
Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT), T. Lencz, E. Knowles, G. Davies, S. Guha, D. C. Liewald, J. M. Starr, S. Djurovic, I. Melle, K. Sundet, A. Christoforou, I. Reinvang, S. Mukherjee, P. DeRosse, A. Lundervold, V. M. Steen, M. John, T. Espeseth, K. Raikkonen, E. Widen, A. Palotie, J. G. Eriksson, I. Giegling, B. Konte, M. Ikeda, P. Roussos, S. Giakoumaki, K. E. Burdick, A. Payton, W. Ollier, M. Horan, G. Donohoe, D. Morris, A. Corvin, M. Gill, N. Pendleton, N. Iwata, A. Darvasi, P. Bitsios, D. Rujescu, J. Lahti, S. L. Hellard, M. C. Keller, O. A. Andreassen, I. J. Deary, D. C. Glahn, and Anil Malhotra
Characteristics, symptomatology and naturalistic treatment in individuals at-risk for bipolar disorders: Baseline results in the first 180 help-seeking individuals assessed at the dresden high-risk project, K. Leopold, S. Ratzer, Christoph Correll, M. Rottmann-Wolf, S. Pfeiffer, P. Ritter, M. Bauer, and A. Pfennig
Erratum to: Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial (vol 157, pg 112, 2014), H. F. Li, J. F. Luo, C. Y. Wang, S. P. Xie, X. F. Xu, X. P. Wang, W. J. Yu, N. F. Gu, and J. M. Kane
Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: A randomized, double-blind, active parallel-controlled, multicenter clinical trial, H. F. Li, J. F. Luo, C. Y. Wang, S. P. Xie, X. F. Xu, X. P. Wang, W. J. Yu, N. F. Gu, and John Kane
alpha 7 Nicotinic Acetylcholine Receptor Signaling Inhibits Inflammasome Activation by Preventing Mitochondrial DNA Release, B. Lu, K. Kwan, Y. A. Levine, P. S. Olofsson, H. Yang, J. H. Li, S. Joshi, H. C. Wang, U. Andersson, S. S. Chavan, and K. J. Tracey
Genes and Schizophrenia: From a Festschrift Seminar Honoring William T. Carpenter Jr, MD, Anil Malhotra
Acanthosis Nigricans During Treatment With Aripiprazole, P. Manu, Z. Al-Dhaher, N. Dargani, and C. U. Correll
Elevated Blood Urea Nitrogen and Medical Outcome of Psychiatric Inpatients, P. Manu, Z. Al-Dhaher, S. Khan, J. M. Kane, and C. U. Correll
Markers of inflammation in schizophrenia: association vs. causation, P. Manu, C. U. Correll, M. Wampers, A. J. Mitchell, M. Probst, D. Vancampfort, and M. De Hert
Dysmetabolic features of the overweight patients receiving antipsychotic drugs: A comparison with normal weight and obese subjects, P. Manu, C. U. Correll, M. Wampers, R. van Winkel, W. Yu, D. Shiffeldrim, and M. De Hert
Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission, P. Manu, S. Khan, R. Radhakrishnan, M. J. Russ, J. M. Kane, and C. U. Correll
The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging, C. M. Marano, C. I. Workman, C. H. Lyman, E. Kramer, C. R. Hermann, Y. L. Ma, V. Dhawan, T. Chaly, D. Eidelberg, and G. S. Smith
The content of attenuated psychotic symptoms in those at clinical high risk for psychosis, C. Marshall, E. Denny, K. S. Cadenhead, T. D. Cannon, Barbara Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, M. T. Tsuang, J. Addington, and +2 additional authors
Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?, X. R. Ma, C. L. Hou, Y. Zang, F. J. Jia, Y. Q. Lin, Y. Li, H. F. Chiu, G. S. Ungvari, Christoph Correll, Y. T. Xiang, and +5 additional authors
Copy Number Variation in Obsessive-Compulsive Disorder and Tourette Syndrome: A Cross-Disorder Study, L. M. McGrath, D. M. Yu, C. Marshall, L. K. Davis, B. Thiruvahindrapuram, B. B. Li, C. Cappi, R. D. Bruun, Cathy Budman, J. M. Scharf, and +112 additional authors
Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach, R. S. McIntyre and Christoph Correll
The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study, E. C. Meyer, Ricardo Carrion, Barbara Cornblatt, J. Addington, K. S. Cadenhead, T. D. Cannon, T. H. McGlashan, D. O. Perkins, M. T. Tsuang, L. J. Seidman, and +3 additional authors
BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: A meta-analysis, I. Miura, Jianping Zhang, M. Nitta, T. Lencz, John Kane, Anil Malhotra, H. Yabe, and Christoph Correll
Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome, C. A. Montojo, A. Ibrahim, K. H. Karlsgodt, C. Chow, A. E. Hilton, R. K. Jonas, T. K. Vesagas, and C. E. Bearden
Excess of homozygosity in the major histocompatibility complex in schizophrenia, S. Mukherjee, S. Guha, M. Ikeda, N. Iwata, Anil Malhotra, I. Pe'er, A. Darvasi, and T. Lencz
Clinical Correlates of Initial Treatment Disengagement in First-Episode Psychosis, N. Myers, S. Bhatty, B. Broussard, and Michael Compton
A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression, J. C. Nelson, P. Baumann, K. Delucchi, R. T. Joffe, and C. Katona
Comment on 'effectiveness and safety of rapid clozapine titration in schizophrenia' Reply, J. Nielsen, P. Ifteni, P. Manu, J. Kane, and C. Correll
Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study, J. Nielsen, S. O. Jensen, R. B. Friis, J. B. Valentin, and Christoph Correll
Risk of Diabetes in Children and Adolescents Exposed to Antipsychotics: A Nationwide 12-Year Case-Control Study, R. E. Nielsen, M. F. Laursen, D. L. Vernal, C. Bisgaard, H. Jakobsen, H. C. Steinhausen, and Christoph Correll
MATRICS cognitive consensus battery (MCCB) performance in children, adolescents, and young adults, G. C. Nitzburg, P. DeRosse, K. E. Burdick, B. D. Peters, C. B. Gopin, and Anil Malhotra
The relationship between temperament and character and subclinical psychotic-like experiences in healthy adults, G. C. Nitzburg, Anil Malhotra, and P. DeRosse
National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians, M. Olfson, C. Blanco, S. Wang, G. Laje, and Christoph Correll
No Causal Association Between Electroconvulsive Therapy and Death A Summary of a Report From the Danish Health and Medicines Authority Covering 99,728 Treatments, S. D. Ostergaard, T. G. Bolwig, and G. Petrides
Risk factors for conversion from unipolar psychotic depression to bipolar disorder, S. D. Ostergaard, S. Straszek, G. Petrides, S. Skadhede, S. O. W. Jensen, P. Munk-Jorgensen, and J. Nielsen
Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial, A. K. Pagsberg, P. Jeppesen, D. G. Klauber, K. G. Jensen, D. Ruda, M. Stentebjerg-Olesen, P. Jantzen, S. Rasmussen, Christoph Correll, B. Fagerlund, and +19 additional authors
Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials, A. K. Pagsberg, S. Tarp, D. Glintborg, A. D. Stenstrom, A. Fink-Jensen, Christoph Correll, and R. Christensen
SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics, I. Palanca-Maresca, B. Ruiz-Antoran, G. Centeno-Soto, S. Jimenez-Fernandez, L. Garcia-Murillo, A. Siles, S. Villagra, H. Blasco-Fontecilla, L. Iruela-Cuadrado, Christoph Correll, and +2 additional authors
Genetic Association Signal Near NTN4 in Tourette Syndrome, P. Paschou, D. M. Yu, G. Gerber, P. Evans, F. Tsetsos, L. K. Davis, Cathy Budman, C. A. Mathews, J. M. Scharf, and +29 additional authors
Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project, D. O. Perkins, C. D. Jeffries, J. Addington, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, Barbara Cornblatt, D. H. Mathalon, S. W. Woods, R. Heinssen, and +4 additional authors
Age-Related Differences in White Matter Tract Microstructure Are Associated with Cognitive Performance from Childhood to Adulthood, B. D. Peters, T. Ikuta, P. DeRosse, M. John, K. E. Burdick, P. Gruner, D. M. Prendergast, Philip Szeszko, and Anil Malhotra
Brain White Matter Development Is Associated with a Human-Specific Haplotype Increasing the Synthesis of Long Chain Fatty Acids, B. D. Peters, A. N. Voineskos, P. R. Szeszko, T. A. Lett, P. DeRosse, S. Guha, K. H. Karlsgodt, M. John, T. Lencz, A. K. Malhotra, and +4 additional authors
Psychotherapeutic interventions in individuals at risk of developing bipolar disorder: a systematic review, A. Pfennig, C. U. Correll, C. Marx, M. Rottmann-Wolf, T. D. Meyer, M. Bauer, and K. Leopold
Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial, A. Pfennig, K. Leopold, A. Bechdolf, C. U. Correll, M. Holtmann, M. Lambert, C. Marx, T. D. Meyer, G. Juckel, M. Bauer, and +5 additional authors
Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics, M. A. Raebel, R. Penfold, A. W. McMahon, M. Reichman, S. Shetterly, G. Goodrich, S. Andrade, C. U. Correll, and T. Gerhard
Delineation of hippocampal subregions using T1-weighted magnetic resonance images at 3 Tesla, K. Rhindress, T. Ikuta, R. Wellington, A. K. Malhotra, and P. Szeszko
Biological insights from 108 schizophrenia-associated genetic loci, S. Ripke, B. M. Neale, A. Corvin, J. T. R. Walters, K. H. Farh, T. Lencz, A. K. Malhotra, Consortium Psychiat Genomics, Conso Psychosis Endophenotypes Int, Consor Wellcome Trust Case-Control, and +292 additional authors
Child and Adolescent Psychiatrists' Attitudes and Practices Prescribing Second Generation Antipsychotics, A. M. Rodday, S. K. Parsons, C. U. Correll, A. S. Robb, B. T. Zima, T. S. Saunders, and L. K. Leslie
Affective temperaments and neurocognitive functioning in bipolar disorder, M. Russo, K. Mahon, M. Shanahan, E. Ramjas, C. Solon, R. Braga, and K. E. Burdick
Initial evidence for sex-specific effects of early emotional abuse on affective processing in bipolar disorder, M. Russo, R. Proujansky, A. Gilbert, R. Braga, and K. E. Burdick
Perceived discrimination in those at clinical high risk for psychosis, M. M. Saleem, J. Stowkowy, K. S. Cadenhead, T. D. Cannon, B. Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, M. T. Tsuang, S. W. Woods, and +2 additional authors
Diabetes risk potentially underestimated in youth and children receiving antipsychotics, K. Samaras, C. U. Correll, A. J. Mitchell, and M. De Hert
Default mode network connectivity and reciprocal social behavior in 22q11.2 deletion syndrome, M. J. Schreiner, K. H. Karlsgodt, L. Q. Uddin, C. Chow, E. Congdon, M. Jalbrzikowski, and C. E. Bearden
Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression, S. Schwartz and C. U. Correll
A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia, J. H. Q. Shen, Y. G. Zhao, S. Rosenzweig-Lipson, D. Popp, J. B. W. Williams, E. Giller, M. J. Detke, and J. Kane
The Social Determinants of Mental Health: An Overview and Call to Action, R. Shim, C. Koplan, F. J. P. Langheim, M. W. Manseau, R. A. Powers, and M. Compton
Datapoints: psychiatrists' perceptions of insurance-related medication access barriers, R. Shim, C. Lally, R. Farley, C. Ingoglia, and B. G. Druss
Medical Care Services in Community Mental Health Centers: a National Survey of Psychiatrists, R. Shim, C. Lally, R. Farley, C. Ingoglia, and B. G. Druss
A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia, B. Stubbs, M. De Hert, A. A. Sepehry, C. U. Correll, A. J. Mitchell, A. Soundy, J. Detraux, and D. Vancampfort
The prevalence and moderators of clinical pain in people with schizophrenia: A systematic review and large scale meta-analysis, B. Stubbs, A. J. Mitchell, M. De Hert, C. U. Correll, A. Soundy, M. Stroobants, and D. Vancampfort
Aggression in Schizophrenia and its Relationship to Neural Circuitry of Urgency, P. Szeszko
White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis, P. Szeszko, D. G. Robinson, T. Ikuta, B. D. Peters, J. Gallego, J. Kane, and A. K. Malhotra
Self-Reported and Interviewer-Rated Oral Health in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder, L. R. Tang, W. Zheng, H. Zhu, X. Ma, H. F. Chiu, C. U. Correll, G. S. Ungvari, Y. Q. Xiang, K. Y. Lai, X. L. Cao, Y. Li, B. L. Zhong, K. I. Lok, and Y. T. Xiang
Functional development in clinical high risk youth: Prediction of schizophrenia versus other psychotic disorders, S. I. Tarbox, J. Addington, K. S. Cadenhead, T. D. Cannon, B. Cornblatt, D. O. Perkins, L. J. Seidman, M. T. Tsuang, E. F. Walker, S. W. Woods, and +2 additional authors
Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment*, N. Toteja, J. Gallego, E. Saito, T. Gerhard, A. Winterstein, M. Olfson, and C. U. Correll
Age-associated alterations in corpus callosum white matter integrity in bipolar disorder assessed using probabilistic tractography, N. Toteja, P. Guvenek-Cokol, T. Ikuta, V. Kafantaris, B. D. Peters, K. E. Burdick, M. John, A. K. Malhotra, and P. Szeszko
Moderator effects of working memory on the stability of ADHD symptoms by dopamine receptor gene polymorphisms during development, J. Trampush, M. M. Jacobs, Y. L. Hurd, J. H. Newcorn, and J. M. Halperin
Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS), H. D. Trotman, C. W. Holtzman, E. F. Walker, J. M. Addington, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, B. Cornblatt, R. K. Heinssen, T. H. McGlashan, and +5 additional authors
Factor analysis of the Scale of Prodromal Symptoms: data from the Early Detection and Intervention for the Prevention of Psychosis Program, I. F. Tso, S. F. Taylor, T. B. Grove, T. Niendam, S. Adelsheim, A. Auther, B. Cornblatt, C. S. Carter, R. Calkins, W. R. McFarlane, and +2 additional authors
Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes, V. Vacic, L. J. Ozelius, L. N. Clark, A. Bar-Shira, M. Gana-Weisz, T. Gurevich, A. Gusev, S. Guha, T. Lencz, A. Orr-Urtreger, and +10 additional authors